Announcing the new book by DermNet NZ

Download a FREE sample chapter

DOWNLOAD NOW

Ataxia-telangiectasia

Author: Vanessa Ngan, Staff Writer, 2003.

What is ataxia-telangiectasia?

Ataxia-telangiectasia is a rare inherited disorder that is characterised by ataxia (lack of co-ordination) and telangiectases (tiny red spider-like veins) on the skin and eyes. Recurrent respiratory infections are another common feature of the disease.

Ataxia-telangiectasia is also known as Louis-Bar syndrome.

What are the signs and symptoms?

Children with ataxia-telangiectasia appear normal at birth and it is not until they learn to walk that it becomes apparent there is a problem. Ataxia results from the progressive degeneration of a part of the brain called the cerebellum. Signs and symptoms of progressive neurological impairment include:

The second major clinical manifestation of ataxia-telangiectasia is the development of telangiectases. These usually do not occur until the child is between 3 and 5 years and may not even be apparent until adolescence. Tiny red spider-like veins first appear around the corners of eyes and then spread to the ears and cheeks.

Patients with ataxia-telangiectasia also have a weakened immune system, which makes them vulnerable to recurrent respiratory infections. They are also at greater risk of getting cancers.

How do you get ataxia-telangiectasia?

Ataxia-telangiectasia is an autosomal recessive inherited disease. This means that you have inherited two ataxia-telangiectasia genes (one from each parent). If your parents are only carriers of ataxia-telangiectasia (each have one ataxia-telangiectasia gene and one normal gene), they will not show any signs of the disease themselves. The responsible gene has been mapped to chromosome band 11q22-23.

Ataxia-telangiectasia may occur in any race or sex. Reported rates of incidence range from 1 in 40,000 to 1 in 100,000 births.

Is there a cure and what is the long-term outcome?

There is no cure for ataxia-telangiectasia. Currently no treatment exists to slow down the progression of the disease. The management of ataxia-telangiectasia is aimed at treating symptoms as they arise, preventing complications and most importantly providing support and education to both patients and their families. Patients with ataxia-telangiectasia usually die in their teenage years or early adulthood as a result of respiratory complications, cancer, or both.

Related information

Make a donation

Donate Today

Help us to update and maintain DermNet New Zealand

Submit your images

We are expanding our image library

Contact us

History of DermNet NZ

Watch Dr Amanda Oakley presenting 'The History Of DermNet NZ' at The International Society Of Teledermatology.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter